SCP
LLY icon

Silverleafe Capital Partners’s Eli Lilly LLY Stock Holding History

Silverleafe Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,192
Closed -$284K – 77
2019
Q1 		$284K Buy
2,192
+382
+21% +$46.5K 0.17% 54
2018
Q4 		$209K Buy
+1,810
New +$202K 0.14% 57

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Silverleafe Capital Partners's LLY Position: Q2 2019 in Review

Silverleafe Capital Partners sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 2,192 shares — an estimated $284K sold.

Silverleafe Capital Partners first reported a position in LLY in Q4 2018 and held it in 2 quarters. The position peaked at $284K in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Silverleafe Capital Partners reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Silverleafe Capital Partners sold 2,192 Eli Lilly shares in Q2 2019, an estimated $284K.
  • Silverleafe Capital Partners first reported a position in Eli Lilly in Q4 2018 and held it in 2 quarters.
  • Silverleafe Capital Partners's Eli Lilly position peaked at $284K in Q1 2019.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Silverleafe Capital Partners's 13F filing for Q2 2019, filed 3 Jul 2019.